Torigen Pharmaceuticals, Inc.
PrivateLast Round
Series A
Extension
Nov 16, 2022
Total Funding Raised
$22.31M
Company Overview
Torigen Pharmaceuticals, Inc. is a biotechnology company that provides personalized cancer immunotherapies for companion animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Non-AI
Keywords
veterinary oncologyautologous cancer vaccinepersonalized immunotherapypet cancer treatmentveterinary biotechnologycompanion animal healthcancer immunotherapyprecision medicineveterinary biologicspet oncologyvet cancer caretumor-specific vaccineveterinary services
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Torigen Pharmaceuticals, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Torigen Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 16, 2022 | ||||
| Series A | Mar 4, 2021 | ||||
| Series A | Feb 18, 2019 | ||||
| Seed | Aug 21, 2018 | ||||
| Convertible Debt | Oct 20, 2017 | ||||
Convertible Debt | Mar 23, 2017 |
Key People
Founding team and executive leadership
Torigen Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A, Seed, Series A Extension, Convertible Debt |
| Emerald Development Managers | Series A Extension, Series A |
| Advantage Capital | Series A Extension |
| Gaingels | Series A Extension, Series A |
| Werth Family Investment Associates | Series A Extension |
| SoGal Ventures | Series A Extension, Series A |
| Sofia Fund | Series A |
Torigen Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Torigen Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersFarmington, Connecticut
Employee Range22
Year Founded2013
Last FundingNov 16, 2022